Background: Amiodarone is a class III antidysrhythmic first released for human use in 1962. As with other drugs in this class, amiodarone acts by blocking potassium channels thus prolonging the action potential. This, in turn, leads to a lengthening of depolarization ...
55 year old male with chief complaint of palpitations. Denies any chest pain, shortness of breath, diaphoresis, or syncope. His past medical history is significant for diastolic congestive heart failure, type 2 diabetes mellitus, hypertension, and hyperlipidemia. Per patient he ...
Differentiating between SVT with aberrancy versus VT can be very difficult. It is crucial to be able to make this distinction as therapeutic decisions are anchored to this differentiation. Brugada et al prospectively analyzed 384 patients with VT and 170 patients ...
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.
